Watch Ticker

Entrada Therapeutics, Inc. Common Stock

Go to Entrada Therapeutics, Inc. Common Stock Website

$5.83

-0.09 (-1.52%)

Live

Previous Close

$5.83

Day Range

$5.68 - $5.99

Previous Day Range

$5.62 - $6.04

Market Cap

$224.7 million USD

Day Vol.

356449

Previous Day Vol.

304715

Currency

USD

Primary Exchange

Nasdaq

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosoma...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program

Entrada Therapeutics announced the recipients of its second annual DREAMS Grant Program, awarding $25,000 each to three U.S. non-profit organizations - CureDuchenne, The Little Hercules Foundation, and Walking Strong - to support programs advancing diversity, equity, inclusion, and accessibility within the Duchenne community.

Related tickers: TRDA.

Read Full Article

N/A - Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top

Nektar Therapeutics reported a wider-than-expected loss in Q2 2024, despite a 14.6% increase in total revenues. The company's lead pipeline candidate, rezpegaldesleukin, is progressing through clinical trials for autoimmune and inflammatory diseases.

Related tickers: NKTR, LLY, EXAS, TRDA.

Read Full Article

Trending Tickers

Please sign in to view